OTC · EQUR
E-Qure Corp.
Healthcare · Medical - Devices
$0.00
Down-$0.04 (-99.50%)
Updated Aug 24, 2026, 5:19 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 6.91K
- P/E ratio
- -0.01
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 15K
- Avg. volume
- 317
Price performance
EQUR price history
1M range · 0 trading sessions · Daily adjusted prices
EQUR does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest EQUR news
The latest Smart Investors Daily articles mentioning EQUR.
Stock researchCompany · Overview
EQUR research
Overview
Company profile and research snapshot.
Company profile
E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
